Vanguard Group’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $329M | Buy |
15,264,240
+61,006
| +0.4% | +$1.32M | 0.01% | 1265 |
|
2025
Q1 | $253M | Buy |
15,203,234
+1,255,594
| +9% | +$20.9M | ﹤0.01% | 1365 |
|
2024
Q4 | $256M | Buy |
13,947,640
+104,444
| +0.8% | +$1.92M | ﹤0.01% | 1423 |
|
2024
Q3 | $213M | Buy |
13,843,196
+131,065
| +1% | +$2.02M | ﹤0.01% | 1513 |
|
2024
Q2 | $223M | Buy |
13,712,131
+413,590
| +3% | +$6.72M | ﹤0.01% | 1439 |
|
2024
Q1 | $246M | Sell |
13,298,541
-97,468
| -0.7% | -$1.8M | ﹤0.01% | 1388 |
|
2023
Q4 | $419M | Sell |
13,396,009
-220,731
| -2% | -$6.91M | 0.01% | 1074 |
|
2023
Q3 | $284M | Sell |
13,616,740
-238,106
| -2% | -$4.96M | 0.01% | 1241 |
|
2023
Q2 | $332M | Buy |
13,854,846
+176,037
| +1% | +$4.22M | 0.01% | 1179 |
|
2023
Q1 | $257M | Buy |
13,678,809
+399,034
| +3% | +$7.51M | 0.01% | 1319 |
|
2022
Q4 | $211M | Buy |
13,279,775
+354,134
| +3% | +$5.64M | 0.01% | 1397 |
|
2022
Q3 | $211M | Buy |
12,925,641
+525,048
| +4% | +$8.59M | 0.01% | 1356 |
|
2022
Q2 | $175M | Sell |
12,400,593
-180,221
| -1% | -$2.54M | ﹤0.01% | 1510 |
|
2022
Q1 | $305M | Buy |
12,580,814
+265,448
| +2% | +$6.43M | 0.01% | 1284 |
|
2021
Q4 | $287M | Buy |
12,315,366
+186,100
| +2% | +$4.34M | 0.01% | 1375 |
|
2021
Q3 | $201M | Buy |
12,129,266
+610,949
| +5% | +$10.1M | 0.01% | 1606 |
|
2021
Q2 | $281M | Buy |
11,518,317
+657,142
| +6% | +$16M | 0.01% | 1410 |
|
2021
Q1 | $280M | Buy |
10,861,175
+255,402
| +2% | +$6.59M | 0.01% | 1367 |
|
2020
Q4 | $567M | Buy |
10,605,773
+236,083
| +2% | +$12.6M | 0.02% | 815 |
|
2020
Q3 | $428M | Sell |
10,369,690
-291,729
| -3% | -$12M | 0.01% | 839 |
|
2020
Q2 | $517M | Sell |
10,661,419
-321,618
| -3% | -$15.6M | 0.02% | 745 |
|
2020
Q1 | $464M | Buy |
10,983,037
+366,424
| +3% | +$15.5M | 0.02% | 692 |
|
2019
Q4 | $454M | Buy |
10,616,613
+105,989
| +1% | +$4.53M | 0.02% | 869 |
|
2019
Q3 | $378M | Buy |
10,510,624
+1,005,542
| +11% | +$36.2M | 0.01% | 943 |
|
2019
Q2 | $254M | Buy |
9,505,082
+7,440
| +0.1% | +$199K | 0.01% | 1211 |
|
2019
Q1 | $255M | Sell |
9,497,642
-644,022
| -6% | -$17.3M | 0.01% | 1185 |
|
2018
Q4 | $164M | Buy |
10,141,664
+1,312,046
| +15% | +$21.2M | 0.01% | 1372 |
|
2018
Q3 | $183M | Buy |
8,829,618
+155,172
| +2% | +$3.22M | 0.01% | 1448 |
|
2018
Q2 | $132M | Buy |
8,674,446
+518,282
| +6% | +$7.91M | 0.01% | 1633 |
|
2018
Q1 | $183M | Buy |
8,156,164
+170,967
| +2% | +$3.84M | 0.01% | 1340 |
|
2017
Q4 | $240M | Buy |
7,985,197
+213,689
| +3% | +$6.43M | 0.01% | 1183 |
|
2017
Q3 | $293M | Buy |
7,771,508
+166,903
| +2% | +$6.29M | 0.01% | 1015 |
|
2017
Q2 | $212M | Buy |
7,604,605
+134,820
| +2% | +$3.76M | 0.01% | 1193 |
|
2017
Q1 | $257M | Buy |
7,469,785
+348,141
| +5% | +$12M | 0.01% | 1054 |
|
2016
Q4 | $205M | Buy |
7,121,644
+252,648
| +4% | +$7.29M | 0.01% | 1142 |
|
2016
Q3 | $219M | Buy |
6,868,996
+500,036
| +8% | +$15.9M | 0.01% | 1054 |
|
2016
Q2 | $207M | Buy |
6,368,960
+49,421
| +0.8% | +$1.6M | 0.01% | 1039 |
|
2016
Q1 | $177M | Buy |
6,319,539
+717,883
| +13% | +$20.1M | 0.01% | 1095 |
|
2015
Q4 | $200M | Buy |
5,601,656
+148,646
| +3% | +$5.3M | 0.01% | 1012 |
|
2015
Q3 | $180M | Buy |
5,453,010
+150,048
| +3% | +$4.96M | 0.01% | 1053 |
|
2015
Q2 | $222M | Buy |
5,302,962
+171,603
| +3% | +$7.19M | 0.02% | 992 |
|
2015
Q1 | $167M | Buy |
5,131,359
+249,158
| +5% | +$8.12M | 0.01% | 1138 |
|
2014
Q4 | $155M | Buy |
4,882,201
+51,584
| +1% | +$1.64M | 0.01% | 1124 |
|
2014
Q3 | $120M | Buy |
4,830,617
+965
| +0% | +$23.9K | 0.01% | 1227 |
|
2014
Q2 | $109M | Buy |
4,829,652
+39,758
| +0.8% | +$898K | 0.01% | 1340 |
|
2014
Q1 | $117M | Buy |
4,789,894
+474,281
| +11% | +$11.5M | 0.01% | 1256 |
|
2013
Q4 | $108M | Buy |
4,315,613
+438,600
| +11% | +$11M | 0.01% | 1268 |
|
2013
Q3 | $107M | Buy |
3,877,013
+954,544
| +33% | +$26.2M | 0.01% | 1200 |
|
2013
Q2 | $53M | Buy |
+2,922,469
| New | +$53M | 0.01% | 1598 |
|